Institut National de la Sante et de la Recherche Medicale

Psychology & Psychiatry

Treating depressive symptoms at their roots

A wide range of compounds is on the market to ameliorate depressive symptoms. However, their efficiency is achieved only after long periods of treatment and not in all patients. Inserm researchers identified early cellular ...

Neuroscience

Medical diagnosis: Will brain palpation soon be possible?

If there is one technique used by the physician to explore the human body during every medical examination in order to make a diagnosis or prescribe further tests, it is palpation. By its nature, however, the brain cannot ...

Diseases, Conditions, Syndromes

Malaria: Multi-drug resistance more alarming than ever

The efforts of the international community for the past ten years in the fight against malaria have reduced the number of disease-related deaths. The emerging resistance to standard therapies threatening South-East Asia, ...

Psychology & Psychiatry

How can one assess the effectiveness of hypnosis?

Although hypnosis has existed for hundreds of years, today it is still difficult to clearly judge its usefulness in the medical domain. In a report submitted to the French Directorate General for Health, researchers from ...

Genetics

A new virus in liver cancer

More than a cause of a simple infection, viruses are often involved in the development of serious diseases. Such is the case with liver cancer, which often develops in an organ that has been weakened by hepatitis B or C virus. ...

Medical research

Irf5, a new player in the occurrence of obesity complications

Metabolic complications of obesity and overweight, such as type 2 diabetes, are an important challenge to public health. Teams led by Nicolas Venteclef, Inserm Research Fellow (Cordeliers Research Centre, Inserm/Pierre and ...

Medical research

Caring for blindness: A new protein in sight?

Vasoproliferative ocular diseases are responsible for sight loss in millions of people in the industrialised countries. Many patients do not currently respond to the treatment offered, which targets a specific factor, VEGF. ...

page 6 from 12